Metabolite results when a drug is metabolized into a modified form which continues to produce effects. Endogenous variables like age, sex, body composition, genetics, and underlying pathologies have an impact on a given body fluid's metabolome. The activity of an enormous variety of enzymes and transporters responsible for the production, transformation, degradation, and compartmentalization of these small molecules typically keeps the levels of the enormous variety of unique small-molecule metabolites tightly regulated. In the brain, endogenous small molecules are typically present at levels that are tightly controlled.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V72352 | (R)-5-Oxopyrrolidine-2-carboxylic acid (D-pyroglutamic acid) | 4042-36-8 | (R)-5-Oxopyrrolidine-2-carboxylic acid is an endogenously produced metabolite. |
|
V70924 | (R)-Mandelonitrile lyase (Mandelonitrile Lyase) | 9024-43-5 | (R)-Mandelonitrile lyase is an enzyme that can be extracted from Prunus species sup>[1]. |
|
V30411 | (R)-Pantetheine | 496-65-1 | (R)-Pantetheine, the R-enantiomer of pantetheine, is a biosynthetic precursor to CoA and also a metabolite in the biosynthesis of secondary metabolites such as carbapenem and pantothenate. |
|
V72380 | (R)-pyrrolidine-2-carboxylic acid (D-proline; (+)-(R)-Proline; (R)-(+)-Proline; (R)-2-Carboxypyrrolidine; (R)-Proline ) | 344-25-2 | (R)-pyrrolidine-2-carboxylic acid is an endogenously produced metabolite. |
|
V82020 | (R)-SEMBL | 1443449-07-7 | (R)-SEMBL (compound 1B) is a potent NF-κB inhibitor. |
|
V80222 | (Rac)-Folic acid-13C5,15N ((Rac)-Vitamin B9-13C5,15N; (Rac)-Vitamin M-13C5,15N) | (Rac)-Folic acid-13C5,15N is a 13C (carbon 13) and 15N (nitrogen 15) labelled Folic acid. | |
|
V72762 | (Rac)-Salvianic acid A ((Rac)-Danshensu; (Rac)-Danshensu) | 23028-17-3 | (Rac)-Salvianic acid A ((Rac)-Danshensu) is a phenolic acid, a potent free radical scavenger and antioxidant. |
|
V72318 | (S)-(-)-Phenylethanol | 1445-91-6 | (S)-(-)-Phenylethanol is an endogenously produced metabolite. |
|
V72616 | (S)-2-acetamido-4-amino-4-oxobutanoic acid | 4033-40-3 | (S)-2-acetamido-4-amino-4-oxobutanoic acid is an endogenously produced metabolite. |
|
V72620 | (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate | 18835-59-1 | (S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate is an endogenously produced metabolite. |
|
V77446 | (S)-Cystathionine-d4 | (S)-Cystathionine-d4 is the deuterium labelled form of (S)-Cystathionine. | |
|
V72806 | (S)-Higenamine ((S)-Norcoclaurine) | 22672-77-1 | (S)-Higenamine ((S)-Norcoclaurine), the S-isomer of Higenamine, is the starting compound for the biosynthesis of benzylisoquinoline alkaloids. |
|
V72663 | (S)-Higenamine hydrobromide ((S)-Norcoclaurine hydrobromide) | 105990-27-0 | (S)-Higenamine ((S)-Norcoclaurine) HBr, the S-isomer of Higenamine, is the starting compound for the biosynthesis of benzylisoquinoline alkaloids. |
|
V77627 | (S)-L-Cystine-15N2 | (S)-L-Cystine-15N2 is L-Cystine labeled with 15N. | |
|
V70971 | (S)-Malic acid-d3 ((S)-Hydroxybutanedioic acid-d3; (S)-E 296-d3) | 59652-74-3 | (S)-Malic acid-d3 is the deuterated form of (S)-Malic acid. |
|
V72744 | (S)-Nornicotine hydrochloride | 101832-65-9 | (S)-Nornicotine (HCl) is an optically active nornicotine compound utilized in study/research of dopamine-related disorders and disease states. |
|
V71095 | (S)-Salsolinol ((-)-Salsolinol) | 27740-96-1 | (S)-Salsolinol ((-)-Salsolinol) is a dopamine-derived endogenously produced metabolite. |
|
V81924 | (S,R,S)-AHPC-Me-C6-NH2 | 2411422-49-4 | (S,R,S)-AHPC-Me-C6-NH2 may be utilized in the preparation /synthesis of PROTAC. |
|
V81903 | (Z)-2-Octenoic acid | 1577-96-4 | Z-2-Octenoic acid is the Z-isomer of 2-Octenoic acid. |
|
V82012 | (Z)-4-Amino-4-oxobut-2-enoic acid | 557-24-4 | (Z)-4-Amino-4-oxobut-2-enoic acid is an endogenously produced metabolite. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
